A dermatologist formerly employed at a dermatological practice in the City of Charlottesville was sentenced to 12 months’ probation, including a period of home confinement and electronic monitoring, for using the Drug Enforcement Administration (DEA) registration number of her co-workers to obtain prescription opioid pain medication. The dermatologist, 48, of Charlottesville, pleaded guilty in March 2021 to three counts of using the DEA registration numbers of another person to obtain one or more controlled substances. According to court documents, between July 2015 and November 2016, she diverted large quantities of injectable meperidine, a Schedule II pain medication, known by the brand name Demerol. She did so by using her own DEA registration number, as well as the DEA registration numbers of other physicians in the practice, without their knowledge or consent, to obtain the drugs from local pharmacies. As part of her plea agreement with the United States, she agreed to pay $33,000 in restitution to victims no later than the date of her sentencing hearing, and to pay all remaining restitution before her period of probation ends. According to government filings, the restitution owed to victims may be as much as $45,000.
